- Home
- SHPH vs UOKA Comparison
SHPH vs UOKA Comparison
Compare SHPH & UOKA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SHPH
- UOKA
- Stock Information
- Founded
- SHPH 2012
- UOKA 2002
- Country
- SHPH United States
- UOKA United Kingdom
- Employees
- SHPH N/A
- UOKA N/A
- Industry
- SHPH Biotechnology: Pharmaceutical Preparations
- UOKA
- Sector
- SHPH Health Care
- UOKA
- Exchange
- SHPH Nasdaq
- UOKA NYSE
- Market Cap
- SHPH 2.3M
- UOKA 2.7M
- IPO Year
- SHPH 2022
- UOKA N/A
- Fundamental
- Price
- SHPH $3.48
- UOKA $2.40
- Analyst Decision
- SHPH
- UOKA
- Analyst Count
- SHPH 0
- UOKA 0
- Target Price
- SHPH N/A
- UOKA N/A
- AVG Volume (30 Days)
- SHPH 189.9K
- UOKA 128.0K
- Earning Date
- SHPH 05-08-2025
- UOKA 08-16-2025
- Dividend Yield
- SHPH N/A
- UOKA N/A
- EPS Growth
- SHPH N/A
- UOKA N/A
- EPS
- SHPH N/A
- UOKA N/A
- Revenue
- SHPH N/A
- UOKA $48,375.00
- Revenue This Year
- SHPH N/A
- UOKA N/A
- Revenue Next Year
- SHPH N/A
- UOKA N/A
- P/E Ratio
- SHPH N/A
- UOKA N/A
- Revenue Growth
- SHPH N/A
- UOKA N/A
- 52 Week Low
- SHPH $3.00
- UOKA $1.98
- 52 Week High
- SHPH $107.40
- UOKA $42.50
- Technical
- Relative Strength Index (RSI)
- SHPH 37.82
- UOKA N/A
- Support Level
- SHPH $3.26
- UOKA N/A
- Resistance Level
- SHPH $4.10
- UOKA N/A
- Average True Range (ATR)
- SHPH 0.52
- UOKA 0.00
- MACD
- SHPH 0.04
- UOKA 0.00
- Stochastic Oscillator
- SHPH 15.08
- UOKA 0.00
About SHPH Shuttle Pharmaceuticals Holdings Inc.
Shuttle Pharmaceuticals Holdings Inc is a clinical-stage pharmaceutical company leveraging its proprietary technology to develop novel therapies designed to cure cancers. The company's goal is to extend the benefits of cancer treatments with surgery, radiation therapy, chemotherapy and immunotherapy. Radiation therapy (RT) is one of the effective modalities for treating cancers. It is developing a pipeline of products designed to address the limitations of the current cancer therapies as well as to extend to the new applications of RT. The company believes that its product candidates will enable the company to deliver cancer treatments that are safer, more reliable and at a greater scale than that of the current standard of care.
About UOKA MDJM LTD
MDJM Ltd is engaged in providing real estate agency services to its real estate developer clients, and provides, on an as-needed basis, real estate consulting services and independent training services. The company generates all of its revenue from Hotel income. The company derives a majority of its revenue from the United Kingdom.